0:01

I want to give some conclusions here

0:03

and thank everyone for their attention.

0:05

I know this is a, I think, a topic a lot of people

0:08

don't like that much, and I'm hoping that going

0:11

over some really classic imaging examples of

0:16

BI-RADS 3 on mammogram, ultrasound, and MRI will

0:20

help to standardize our use of BI-RADS 3 and

0:24

make sure that we're only

0:26

using it when it's appropriate.

0:28

I want to emphasize a few points before we finish.

0:31

So first is that we only want to be using

0:34

BI-RADS 3 for specific imaging findings that have

0:39

evidence that there's a chance of a malignancy greater

0:41

than 0% but less than or equal to 2%.

0:44

This is not an intermediate category that we

0:46

should be using when we're just unsure what to do.

0:49

It should be to follow a very

0:50

specific imaging findings.

0:54

We only want to use BI-RADS 3

0:56

after we've done a full diagnostic workup.

0:58

So we never give BI-RADS 3

1:00

directly from a screening exam.

1:03

And finally, I just want to emphasize that we

1:05

have really good data for these indications for

1:07

BI-RADS 3 on mammogram and ultrasound, and we

1:10

should feel very confident that it's very safe

1:13

to use them for the imaging

1:14

findings that we reviewed today.

1:17

The data for BI-RADS 3 on MRI is still evolving

1:20

and I think this could definitely change in

1:22

the coming years, and we want to be flexible

1:25

in our use of it and following the literature

1:28

so we can make sure that we continue to use

1:30

BI-RADS 3 in an appropriate fashion on MRI.

1:33

I want to thank everybody so much for their

1:37

attention, and I hope that I, uh, I was

1:40

able to clarify this challenging topic.

1:43

Thank you.